Summit Investment Advisors Inc. Sells 25,280 Shares of Envista Holdings Co. (NYSE:NVST)

Summit Investment Advisors Inc. decreased its stake in shares of Envista Holdings Co. (NYSE:NVST) by 42.3% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 34,496 shares of the company’s stock after selling 25,280 shares during the period. Summit Investment Advisors Inc.’s holdings in Envista were worth $665,000 at the end of the most recent reporting period.

A number of other large investors have also added to or reduced their stakes in NVST. Thurston Springer Miller Herd & Titak Inc. purchased a new position in shares of Envista in the 4th quarter worth $53,000. Lecap Asset Management Ltd. purchased a new position in Envista in the fourth quarter worth about $281,000. Geode Capital Management LLC boosted its position in Envista by 2.5% in the third quarter. Geode Capital Management LLC now owns 2,895,653 shares of the company’s stock worth $57,233,000 after purchasing an additional 71,435 shares during the last quarter. Hantz Financial Services Inc. grew its stake in shares of Envista by 146.6% during the 4th quarter. Hantz Financial Services Inc. now owns 110,489 shares of the company’s stock valued at $2,131,000 after purchasing an additional 65,679 shares during the period. Finally, Norges Bank purchased a new stake in shares of Envista during the 4th quarter valued at about $38,052,000.

Envista Trading Up 1.1 %

Shares of NVST stock opened at $15.19 on Friday. The company has a current ratio of 2.04, a quick ratio of 1.76 and a debt-to-equity ratio of 0.44. The stock has a market capitalization of $2.62 billion, a price-to-earnings ratio of -2.34, a price-to-earnings-growth ratio of 1.27 and a beta of 1.12. Envista Holdings Co. has a 12-month low of $14.22 and a 12-month high of $23.00. The stock’s 50-day moving average price is $17.82 and its 200-day moving average price is $19.21.

Envista (NYSE:NVST) last issued its quarterly earnings data on Wednesday, February 5th. The company reported $0.24 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.23 by $0.01. Envista had a positive return on equity of 3.86% and a negative net margin of 44.56%. Equities research analysts predict that Envista Holdings Co. will post 1 EPS for the current fiscal year.

Analysts Set New Price Targets

NVST has been the subject of several recent research reports. Needham & Company LLC restated a “hold” rating on shares of Envista in a research report on Thursday, March 6th. New Street Research set a $19.00 price objective on shares of Envista in a research report on Thursday, March 6th. Morgan Stanley set a $16.00 price objective on Envista in a research note on Tuesday. JPMorgan Chase & Co. lowered their target price on Envista from $20.00 to $19.00 and set a “neutral” rating on the stock in a research report on Thursday, March 6th. Finally, Wells Fargo & Company set a $19.00 price target on Envista in a report on Saturday, March 8th. Two analysts have rated the stock with a sell rating, ten have assigned a hold rating and three have assigned a buy rating to the company. Based on data from MarketBeat, Envista presently has an average rating of “Hold” and a consensus price target of $19.96.

Envista Company Profile

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.